Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03117660 · ClinicalTrials.gov registry record · Phase 1
Effects of Retinoids on CYP2D6 Activity During Pregnancy
A Phase 1 study of CYP2D6 Polymorphism, sponsored by University of Washington.
- Completed
- Registry status
- Phase 1
- Development phase
- 82
- Enrollment target
- 1
- Study location
NCT03117660 is a Phase 1 study of CYP2D6 Polymorphism that has completed, run by University of Washington. The registered enrollment target is 82 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03117660, a Phase 1 study of CYP2D6 Polymorphism, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 82 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective drug interaction study during pregnancy.
Conditions Studied
Interventions
- DRUG Vitamin A
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2017-07-25 |
| Est. Completion | 2022-10-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03117660
The ClinicalTrials.gov registry entry for NCT03117660 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with CYP2D6 Polymorphism appearing as the primary indexed condition, and to 1 intervention - of which Vitamin A is the first listed.
NCT03117660 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT03117660 about?
NCT03117660 is a clinical study titled "Effects of Retinoids on CYP2D6 Activity During Pregnancy". Prospective drug interaction study during pregnancy.
What is the current status of trial NCT03117660?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 82 participants. The study started on 2017-07-25. Estimated completion is 2022-10-31.
What conditions does trial NCT03117660 study?
This clinical trial studies the following conditions: CYP2D6 Polymorphism.
What interventions are being tested in trial NCT03117660?
The interventions under investigation include: Vitamin A (DRUG).
Who is sponsoring clinical trial NCT03117660?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03117660 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for CYP2D6 Polymorphism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.